(KHRNF) – PRNewswire
-
Khiron begins dispensation of insurance-covered prescriptions in Colombia
-
NHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patient
-
Khiron wins first medical cannabis contract with Colombia's largest public insurance company
-
Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products
-
Khiron Life Sciences Reports Third Quarter 2022 Financial Results
-
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
-
Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom
-
Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference
-
Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California
-
Khiron Life Sciences Reports Second Quarter 2022 Financial Results
-
Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022
-
Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic
-
Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities
-
Khiron Appoints Helen Bellwood (ACA) as Interim CFO
-
Medical Cannabis Leader Khiron Continues Global Expansion into Spain
-
Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin America
-
Khiron Announces Results of 2022 Annual General and Special Meeting
-
Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint
-
Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis
-
Khiron to Host First Quarter 2022 Conference Call on May 31, 2022
-
Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022
-
Khiron Life Sciences Reports 2021 Fiscal Year End Results
-
Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022
-
Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia
-
LEADING GLOBAL MEDICAL CANNABIS COMPANY KHIRON PUBLISHES CLINICAL STUDY ON THE EFFECTIVENESS OF ITS PRODUCTS AT CONTROLLING CHRONIC PAIN
-
Medical Cannabis Innovator Khiron Continues to Disrupt Global Marketplace Signing Partnership with Teleton in Mexico
-
Khiron Life Sciences to Present at Upcoming March Investor Conferences
-
Khiron Adds Another Clinic Location in Peru
-
Khiron Opens New Medical Cannabis Clinic in Colombia
-
Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians
-
Khiron to Participate in the Lytham Partners Winter 2021 Investor Conference
-
Khiron Announces Grants of Options and Restricted Share Units
-
Khiron Reports Q3 Results - Revenue Increased 83% YoY, 26% QoQ
-
Khiron to Host Third Quarter 2021 Conference Call on November 22, 2021
-
Khiron Life Sciences to Present at Upcoming November Investor Conferences
-
Khiron Opens First clinic in Europe with Zerenia™ Clinics UK
-
Khiron presents its first research study with 1,400 patients
-
Khiron Life Sciences to Present at Upcoming October Investor Conferences
-
Khiron reports medical cannabis prescription growth in South America and Europe
-
Khiron's Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO
-
Khiron Receives Approval To Renew Its Normal Course Issuer Bid
-
Khiron Announces Intention to Renew its Normal Course Issuer Bid
-
Khiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale Nationwide
-
Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany
-
Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021
-
Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership
-
Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil
-
Colombia Expands Distribution of Medical Cannabis to Pharmacies Nationwide and Opens Export Market for Dried Flower Medical Cannabis
-
Khiron Announces Results of 2021 Annual General Meeting
-
Khiron successfully completes first medical cannabis sale in Brazil
Back to KHRNF Stock Lookup